Final ID:
Verma Aradhana, Fonarow Gregg, Heidenreich Paul, Sandhu Alexander
Effects of Sodium-Glucose Cotransporter-2 Inhibitor Use on Major Adverse Cardiovascular Events in Participants With Type 2 Diabetes and Atherosclerotic Cardiovascular Disease Treated With Tirzepatide Versus Dulaglutide (SURPASS-CVOT)D'alessio David, Nicholls Stephen